Real World Study of Linperlisib for Lymphoma Treatment

Real World Study of Linperlisib for Lymphoma Treatment: Multicenter, Non-interventional and Observational Real-world Study

This is a multicenter, non-interventional and observational real-world study to evaluate the efficacy and safety of linperlisib in patients with lymphoma.

Inclusion Criteria:

1. Age ≥18 years
2. Clinical diagnosis of lymphoma patients
3. Patients signed informed consent, volunteered to join the study, and had the willingness and ability to cooperate with the data collection in this study;
4. The researchers' assessment can use Linperlisib treatment

Exclusion Criteria:

1. The nature of the study could not be understood or informed consent was not obtained
2. Other ineligible conditions were assessed by the investigator